Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...
Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...
The cases highlight the effectiveness of rapid coordination between frontline healthcare facilities and specialised hospitals ...
Medical Device Network on MSN
Medtronic’s OmniaSecure defib lead nets another FDA approval
OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.
Short for atrial fibrillation, A-fib is a quivering or irregular heartbeat that is a worrisome stage-setter for blood clots, ...
A heart emergency can occur for a person at home, just as it can occur anywhere else. When this happens, the emergency ...
Background Optimisation of medical therapy is recommended for patients with newly diagnosed non-ischaemic cardiomyopathies (NICM) before consideration of a primary preventive implantable ...
Intraoperative cardiac arrests (ICAs) are low-frequency, high-mortality and morbidity situations. Due to the rarity of occurrence, staff are often not adequately prepared to respond effectively.
Atrial fibrillation (AFib) is the most common cardiac arrhythmia worldwide and a major contributor to heart failure (HF), ...
Electrical signals tell the heart to contract, but when the signals form spiral waves, they can lead to dangerous cardiac events like tachycardia and fibrillation. Researchers are bringing a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results